Discontinuation report CEFZIL TABLETS - 500MG

Last updated on 2017-08-01 History
Report ID 3074
Drug Identification Number 02163667
Brand name CEFZIL TABLETS - 500MG
Common or Proper name Cefprozil
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFPROZIL
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 BTL X 100
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-07-31
Remaining supply date 2017-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-16 English Compare
v2 2017-03-16 French Compare
v3 2017-04-03 English Compare
v4 2017-04-03 French Compare
v5 2017-08-01 English Compare

Showing 1 to 5 of 5